ReferIndia News 'Health Risk': Novo Nordisk Sues Hims & Hers Over Cheaper Version Of Ozempic, Wegovy Fat Loss Pills

ReferIndia News

Want to grow your business digitally?

Let us help you get there—fast, smart, and effective.

Contact Now
News Image

'Health Risk': Novo Nordisk Sues Hims & Hers Over Cheaper Version Of Ozempic, Wegovy Fat Loss Pills

Published on: Feb. 9, 2026, 7:31 p.m. | Source: NDTV Profit

Hims had planned to sell the drug at a sharply discounted price of $49 for the first month, which is almost $100 less than Novo's approved Wegovy pill.

Checkout more news
Ad Banner

Looking for free cloud deployment?

Sign up & get $200 free credit for 60 days to launch your first Droplet or GPU server on DigitalOcean 🚀

Signup Now
ReferIndia News contact